Research & Development
CBD MEDS dedicates its own resources towards the further advancement of both it botanical extraction process and its two CBD cannabis strains. CBD MEDS has a pending patent with the United States Trademark and Patent Commission for both of these proprietary company assets.
CBD MEDS also reinvests it revenues into its customer database, where 1st hand documentation is studied pertaining to the medical benefits attributed by its CBD products to its customers. The data inputted in our system helps to better understand CBD and which medical conditions it is most effective for. We are not only documenting each of our patient’s medical experiences on a case by case basis, but we are also soliciting assistance by major California universities and private investors for the funding of clinical trials.
It is our objective that on the day the FDA decides to allow CBD for human clinical trials, that CBD MEDS will have enough of its own documented research to obtain FDA approval for federal testing.